Tempus Wealth Planning LLC Acquires New Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Tempus Wealth Planning LLC bought a new position in Molina Healthcare, Inc. (NYSE:MOH) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund bought 824 shares of the company’s stock, valued at approximately $240,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Public Sector Pension Investment Board boosted its position in Molina Healthcare by 13.5% in the third quarter. Public Sector Pension Investment Board now owns 2,527 shares of the company’s stock worth $871,000 after purchasing an additional 300 shares during the last quarter. CWM LLC lifted its stake in shares of Molina Healthcare by 76.2% in the 3rd quarter. CWM LLC now owns 4,001 shares of the company’s stock worth $1,379,000 after purchasing an additional 1,730 shares during the period. Tributary Capital Management LLC boosted its holdings in shares of Molina Healthcare by 76.1% in the fourth quarter. Tributary Capital Management LLC now owns 4,190 shares of the company’s stock worth $1,219,000 after buying an additional 1,811 shares during the last quarter. Everence Capital Management Inc. bought a new stake in Molina Healthcare during the fourth quarter valued at approximately $544,000. Finally, Oddo BHF Asset Management Sas purchased a new stake in Molina Healthcare during the third quarter valued at approximately $2,947,000. 98.50% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

MOH has been the subject of a number of recent research reports. Wells Fargo & Company boosted their price objective on shares of Molina Healthcare from $360.00 to $362.00 and gave the company an “equal weight” rating in a research report on Monday, November 4th. Barclays upped their price target on Molina Healthcare from $359.00 to $372.00 and gave the stock an “equal weight” rating in a research report on Friday, October 25th. Robert W. Baird lowered their price objective on Molina Healthcare from $405.00 to $331.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. StockNews.com upgraded Molina Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Friday, January 31st. Finally, JPMorgan Chase & Co. restated a “neutral” rating and set a $350.00 target price (down previously from $378.00) on shares of Molina Healthcare in a research note on Tuesday, December 17th. One analyst has rated the stock with a sell rating, six have given a hold rating, four have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, Molina Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $359.18.

Molina Healthcare Price Performance

Shares of NYSE:MOH opened at $315.46 on Wednesday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.55 and a current ratio of 1.54. The firm has a market cap of $18.04 billion, a price-to-earnings ratio of 16.02, a P/E/G ratio of 0.96 and a beta of 0.54. The firm has a fifty day moving average price of $298.36 and a 200 day moving average price of $318.39. Molina Healthcare, Inc. has a fifty-two week low of $272.69 and a fifty-two week high of $423.92.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.